Related Experiment Videos

Influence of c-myc on the progression of human breast cancer

P H Watson¹, R Singh, A K Hole

¹Department of Pathology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

Current Topics in Microbiology and Immunology

|January 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Factors that drive the increasing use of FFPE tissue in basic and translational cancer research.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2018

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.

Oncogene·2013

Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.

British journal of cancer·2012

S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.

Oncogene·2010

Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.

Histopathology·2008

See all related articles